Sustainable fabrication of biodegradable polycaprolactone/ZnO electrospun scaffolds: centroid-mediated solvent optimization strategy
RSC Advances · 2026 · 16 (37) · 40307-40317
DOI: 10.1039/d6ra03293a ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Arpita Banerjee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Multiscale Microstructure and Mechanics of Materials Division, CSIR-Central Glass and Ceramics Research Institute Jadavpur Kolkata West Bengal 700032…. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Council of Scientific and Industrial Research, India.
Abstract (Originalsprache)
(i) Easy approach for solvent selection (reduces trial, chemical waste and toxicity). (ii) Ecofriendly route for biodegradable scaffolds. (iii) Balanced affinity towards polymer and nanoparticles.
Autor:innen und Institutionen
- Multiscale Microstructure and Mechanics of Materials Division, CSIR-Central Glass and Ceramics Research Institute Jadavpur Kolkata West Bengal 700032 India mousumi.cgcri@csir.res.in.
ORCID-Profile: Arpita Banerjee, Mousumi Majumder
Förderung
- Council of Scientific and Industrial Research, India
Zitieren
APA
Banerjee, A., & Majumder, M. (2026). Sustainable fabrication of biodegradable polycaprolactone/ZnO electrospun scaffolds: centroid-mediated solvent optimization strategy. RSC Advances, 16(37), 40307-40317. https://doi.org/10.1039/d6ra03293a
Vancouver
Banerjee A, Majumder M. Sustainable fabrication of biodegradable polycaprolactone/ZnO electrospun scaffolds: centroid-mediated solvent optimization strategy. RSC Advances. 2026;16(37):40307-40317. doi:10.1039/d6ra03293a
BibTeX
@article{Banerjee2026,
author = {Banerjee, Arpita and Majumder, Mousumi},
title = {Sustainable fabrication of biodegradable polycaprolactone/ZnO electrospun scaffolds: centroid-mediated solvent optimization strategy},
journal = {RSC Advances},
year = {2026},
volume = {16},
number = {37},
pages = {40307--40317},
doi = {10.1039/d6ra03293a}
}
EUVIMED